P2‐032: Withdrawn

(active form), while had no effect on the level of Tyrosine-307phosphorylated PP-2A. Unexpectedly, 5-HT1A agonist 8-OHDPAT did not decrease forskolin-induced tau hyperphophorylation. Conclusions:Escitalopram could protect forskolin-induced tau hyperphosphorylation at multiple AD-related sites, and the mechanism involves inactivation of GSK-3b. Our findings suggest that escitalopram could be a promising therapeutic target for AD-like tau hyperphosphorylation, this may support a potential effective role of antidepressants, at least of the SSRI class, in the prevention of dementia associated with depression in patients.